News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
743,262 Results
Type
Article (54320)
Company Profile (340)
Press Release (688602)
Section
Business (216467)
Career Advice (2851)
Deals (37514)
Drug Delivery (110)
Drug Development (85989)
Employer Resources (179)
FDA (17450)
Job Trends (15868)
News (368814)
Policy (36642)
Tag
Academia (2837)
Alliances (52735)
Alzheimer's disease (1325)
Approvals (17351)
Artificial intelligence (137)
Bankruptcy (382)
Best Places to Work (11991)
Biotechnology (234)
Breast cancer (124)
Cancer (1106)
Cardiovascular disease (97)
Career advice (2383)
Cell therapy (250)
Clinical research (67953)
Collaboration (391)
Compensation (195)
COVID-19 (2773)
C-suite (95)
Data (1065)
Diabetes (165)
Diagnostics (6450)
Drug pricing (99)
Earnings (88192)
Employer resources (157)
Events (116589)
Executive appointments (289)
FDA (17971)
Funding (341)
Gene therapy (191)
GLP-1 (681)
Government (4770)
Healthcare (19731)
Infectious disease (2864)
Inflammatory bowel disease (116)
Interviews (518)
IPO (16948)
Job creations (4247)
Job search strategy (2000)
Layoffs (476)
Legal (9137)
Lung cancer (182)
Manufacturing (191)
Medical device (13934)
Medtech (13939)
Mergers & acquisitions (20605)
Metabolic disorders (454)
Neuroscience (1610)
NextGen Class of 2024 (7018)
Non-profit (4766)
Northern California (1442)
Obesity (264)
Opinion (215)
Patents (106)
People (60225)
Phase I (21011)
Phase II (29726)
Phase III (22446)
Pipeline (451)
Postmarket research (2939)
Preclinical (9040)
Radiopharmaceuticals (248)
Rare diseases (229)
Real estate (6529)
Regulatory (24117)
Research institute (2542)
Resumes & cover letters (472)
Southern California (1298)
Startups (3916)
United States (13542)
Vaccines (643)
Weight loss (214)
Date
Last 7 days (946)
Last 30 days (3581)
Last 365 days (37085)
2024 (33621)
2023 (41760)
2022 (53090)
2021 (57710)
2020 (56287)
2019 (49224)
2018 (37249)
2017 (34903)
2016 (35155)
2015 (40955)
2014 (35142)
2013 (30037)
2012 (32265)
2011 (32846)
2010 (31009)
Location
Africa (904)
Arizona (204)
Asia (42036)
Australia (6977)
California (3292)
Canada (1262)
China (247)
Colorado (146)
Connecticut (155)
Europe (94041)
Florida (447)
Georgia (116)
Illinois (368)
Indiana (200)
Kansas (98)
Maryland (597)
Massachusetts (2616)
Michigan (161)
Minnesota (280)
New Jersey (950)
New York (949)
North Carolina (770)
Northern California (1442)
Ohio (138)
Pennsylvania (828)
South America (1325)
Southern California (1298)
Texas (448)
Washington State (362)
743,262 Results for "canon u s a inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Canon Medical Components U.S.A., Inc. Announces Launch of New Products in the U.S., to be on Display at RSNA 2022
Canon Medical Components U.S.A., Inc., a subsidiary of Canon Inc., announced new products line-up at the Radiology Society of North America conference and annual meeting, held November 27 through November 30 at the McCormick Place Convention Center in Chicago, Illinois.
November 29, 2022
·
5 min read
Pharm Country
Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke
Helius Medical Technologies, Inc. announced the completion of site participation enrollment for its stroke registrational program in the U.S. with the addition of REHABOLOGYM, Neurology Center of New England, and MGH Institute of Health Professions.
June 17, 2024
·
10 min read
BIOSECURE Act
WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow
WuXi AppTec looks to unload its Philadelphia manufacturing sites and WuXi Biologics slows its rapid expansion in the U.S. as the companies await the Senate’s review of the BIOSECURE Act that threatens to cut them off from U.S. biopharma.
October 8, 2024
·
5 min read
·
Ben Hargreaves
Press Releases
RxCell Inc. Granted U.S. Patent for iPSC-based Cell Therapy
September 19, 2024
·
2 min read
Pharm Country
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)
CorMedix Inc. today announced DefenCath® (taurolidine and heparin) catheter lock solution (CLS) is now commercially available for U.S. inpatient use.
April 15, 2024
·
4 min read
Press Releases
60 Degrees Pharmaceuticals Inc. Announces ARAKODA® Promotional Pilot in Advance of Expanded U.S. Launch
October 3, 2024
·
8 min read
FDA
Accord BioPharma, Inc. Announces U.S. Food & Drug Administration Approval of HERCESSI™ (trastuzumab-strf)
Accord BioPharma , Inc. announced that the U.S. Food and Drug Administration (FDA) has approved HERCESSI™ (trastuzumab-strf), a biosimilar to Herceptin® (trastuzumab), to treat HER2-overexpressing breast and gastric or gastroesophageal junction adenocarcinoma.
April 29, 2024
·
11 min read
Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®
Axogen, Inc. is pleased to announce that it has initiated the rolling submission process with the U.S. Food and Drug Administration for a Biologics License Application (BLA) for licensure of Avance Nerve Graft ® on May 15, 2024.
May 16, 2024
·
7 min read
Catalyst Pharmaceuticals Receives U.S. FDA Approval For Increased Maximum Daily Dose For FIRDAPSE®
Catalyst Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (“FDA”) has approved its supplemental New Drug Application (“sNDA”) increasing the indicated maximum daily dose of FIRDAPSE.
May 30, 2024
·
4 min read
BioCapital
NAPIGEN, Inc. Secures U.S. Patent, Awarded USDA SBIR Grant
The U.S. Patent and Trademark Office has issued a patent, US11920140, for the use of CRISPR technologies to edit organellar genomes to NAPIGEN, Inc., a biotechnology company that specializes in mitochondrial and chloroplast genome engineering.
March 11, 2024
·
2 min read
1 of 74,327
Next
